News

Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million

The combined company will operate under the name “ImageneBio, Inc.” and will begin trading on Nasdaq under the ticker symbol ...

BRIEF-Design Capital Expects S$2.0 Million-S$2.5 Million Loss For HY

July 25 (Reuters) - Design Capital Ltd: ...

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has ...